Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer N. XuP. ShenW. J. Fang Original Article 14 April 2006 Pages: 1 - 7
A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management Jeong Won JangSi Hyun BaeSeung Kew Yoon Original Article 14 April 2006 Pages: 9 - 15
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer Keon Woo ParkJin Seok AhnSoon Il Lee Original Article 24 May 2006 Pages: 17 - 21
Thalidomide and celecoxib as potential modulators of irinotecan’s activity in cancer patients Miguel Villalona-CaleroLarry SchaafJohn Kuhn Original Article 10 May 2006 Pages: 23 - 33
Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study Javier de CastroAmalio OrdóñezManuel González Barón Original Article 28 July 2006 Pages: 35 - 42
A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application S. A. VeltkampC. Alderden-LosJ. H. M. Schellens Original Article 06 May 2006 Pages: 43 - 50
A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens Christos KosmasNicolas TsavarisHaralambos P. Kalofonos Original Article 19 April 2006 Pages: 51 - 59
Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties Veronika JekerleWerner KlinkhammerMichael Wiese Original Article 25 April 2006 Pages: 61 - 69
Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis C. K. L. P. BatistaJ. M. S. C. MotaR. A. Ribeiro Original Article 17 May 2006 Pages: 71 - 77
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer R. O’ConnorM. O’LearyJ. Crown Original Article 27 April 2006 Pages: 79 - 87
Fatality involving vinblastine overdose as a result of a complex medical error Małgorzata KłysTomasz KonopkaPiotr Kowalski Original Article 08 July 2006 Pages: 89 - 95
Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients Josephia R. MuindiYibing PengDonald L. Trump Original Article 06 May 2006 Pages: 97 - 104
Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers Maria L. N. DiasJesus P. CarvalhoRaul C. Maranhão Original Article 13 May 2006 Pages: 105 - 111
Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha Kotaro MiyakeKunihiro TsuchidaMitsuo Shimada Original Article 13 May 2006 Pages: 113 - 126
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide Jan S. MorebDagmara MuhoczyJames R. Zucali Original Article 14 April 2006 Pages: 127 - 136
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide Jan S. MorebDagmara MohuczyJames R. Zucali Erratum 30 May 2006 Pages: 137 - 137
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors Herbert I. HurwitzRoger B. CohenTomoko Yoshinari Clinical Trial Report 04 July 2006 Pages: 139 - 147
Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma Camillo PortaLuciano MuttiGianfranco Tassi Letter to the Editor 25 April 2006 Pages: 149 - 150
